Using Regenerative Medicine to Treat Chronic Tendinopathy

June 10, 2026

What Is Chronic Tendinopathy?

Chronic tendinopathy is a common musculoskeletal condition that develops when a tendon experiences ongoing degeneration, irritation, and dysfunction. Unlike acute tendon injuries that result from a sudden strain or tear, chronic tendinopathy typically develops over time due to repetitive stress, overuse, aging, or inadequate healing following an injury.

Chronic tendinopathy most commonly affects the shoulder, elbow, hip, knee, and Achilles tendon. Individuals with this condition often experience persistent pain, stiffness, weakness, and reduced function that can interfere with daily activities, work, exercise, and overall quality of life.

As traditional treatments do not always provide lasting relief, many patients are exploring regenerative medicine as a potential option for chronic tendinopathy treatment.

Why Can Chronic Tendinopathy Be Difficult to Treat?

Chronic tendinopathy can be difficult to treat because tendons have a relatively limited blood supply compared to muscles and other tissues. This reduced circulation can slow the body’s natural healing process.

Over time, repeated stress on the tendon may lead to microscopic damage and degeneration of collagen fibers. Instead of progressing through a normal healing cycle, the tendon can remain in a state of chronic dysfunction.

While treatments such as rest, physical therapy, anti-inflammatory medications, bracing, and corticosteroid injections may help reduce symptoms, they do not always address the underlying tissue degeneration that contributes to chronic tendinopathy.

What Is Regenerative Medicine?

Regenerative medicine is a rapidly growing field focused on supporting the body’s natural healing mechanisms. Rather than simply masking symptoms, regenerative therapies aim to stimulate tissue repair and regeneration at the site of injury.

In orthopedic and pain management settings, regenerative medicine techniques are increasingly being used to treat chronic tendon injuries, ligament damage, joint pain, and certain musculoskeletal conditions.

For patients with chronic tendinopathy, regenerative medicine may offer a minimally invasive alternative to surgery while potentially promoting long-term healing.

How Does Regenerative Medicine Help Chronic Tendinopathy?

Regenerative medicine helps chronic tendinopathy by delivering biological components that may encourage tissue repair and healing. These treatments are typically injected directly into the affected tendon using advanced imaging guidance to ensure precise placement.

The goal is to stimulate a healing response within damaged tendon tissue, improve collagen organization, reduce inflammation, and support the restoration of normal tendon function.

Because chronic tendinopathy often involves tendon degeneration rather than active inflammation alone, regenerative therapies may address factors that traditional treatments do not fully target.

What Is Platelet-Rich Plasma (PRP) Therapy?

Platelet-rich plasma (PRP) therapy is one of the most commonly used regenerative medicine treatments for chronic tendinopathy.

PRP is created by drawing a small sample of the patient’s blood and processing it in a centrifuge to concentrate platelets and growth factors. The concentrated PRP solution is then injected into the damaged tendon.

Platelets contain proteins and signaling molecules that play a critical role in tissue repair. By delivering a higher concentration of these healing components directly to the injured tendon, PRP therapy may help stimulate recovery and improve function.

PRP has been studied for various tendon conditions, including:

  • Tennis elbow (lateral epicondylitis)
  • Golfer’s elbow
  • Rotator cuff tendinopathy
  • Patellar tendinopathy
  • Achilles tendinopathy
  • Gluteal tendinopathy

What Is Bone Marrow Aspirate Concentrate (BMAC)?

Bone marrow aspirate concentrate (BMAC) is another regenerative medicine treatment used in some cases of chronic musculoskeletal injury.

BMAC is obtained by collecting bone marrow, typically from the pelvis, and processing it to concentrate healing cells and growth factors. The concentrated material is then injected into the affected area.

Because BMAC contains biologically active components that may support tissue repair, some specialists use it for patients with chronic tendon injuries that have not responded to conventional treatment.

The appropriateness of BMAC varies depending on the patient’s condition, medical history, and treatment goals.

Which Tendon Conditions May Benefit from Regenerative Medicine?

Several chronic tendon disorders may potentially benefit from regenerative medicine treatments.

  • Chronic Achilles tendinopathy
  • Patellar tendinopathy (jumper’s knee)
  • Rotator cuff tendinopathy
  • Tennis elbow
  • Golfer’s elbow
  • Hamstring tendinopathy
  • Gluteal tendinopathy
  • Chronic quadriceps tendinopathy

What Can Patients Expect During Treatment?

Regenerative medicine treatments are typically performed in an outpatient setting. Most procedures require little downtime and can often be completed within an hour.

Ultrasound or fluoroscopic imaging may be used to guide the injection and improve accuracy. Following treatment, patients may experience temporary soreness at the injection site as the body’s healing response begins.

A structured rehabilitation program is often recommended after treatment. Physical therapy, activity modification, and gradual strengthening exercises can help optimize results and support tendon recovery.

Because healing occurs gradually, improvements may develop over several weeks or months rather than immediately after treatment.

Is Regenerative Medicine a Replacement for Physical Therapy?

Regenerative medicine is not typically considered a replacement for physical therapy. Instead, the two approaches often work together.

Physical therapy remains one of the most important components of chronic tendinopathy treatment because it helps restore strength, flexibility, movement patterns, and tendon loading capacity.

When combined with appropriate rehabilitation, regenerative medicine treatments may help create an environment that supports tissue healing while physical therapy addresses functional recovery.

Who May Be a Candidate for Regenerative Medicine?

Candidates for regenerative medicine often include individuals who:

  • Have chronic tendon pain lasting several months or longer
  • Have not responded adequately to conservative treatments
  • Want to avoid or delay surgery
  • Are seeking minimally invasive treatment options
  • Have imaging findings consistent with tendon degeneration

A comprehensive evaluation, including physical examination and diagnostic imaging, can help determine whether regenerative medicine is an appropriate option.

Can Regenerative Medicine Help Patients Return to Activity?

Many patients pursue regenerative medicine with the goal of returning to work, sports, exercise, and daily activities with less pain and improved function.

While individual results vary, regenerative medicine may help support healing in damaged tendon tissue and reduce the limitations associated with chronic tendinopathy. Success often depends on factors such as the severity of tendon damage, overall health, rehabilitation participation, and adherence to treatment recommendations.

Conclusion

Chronic tendinopathy can be frustrating and difficult to overcome, especially when symptoms persist despite traditional treatments. Regenerative medicine offers an innovative approach that focuses on supporting the body’s natural healing processes rather than simply managing pain.

Treatments such as platelet-rich plasma (PRP) and bone marrow aspirate concentrate (BMAC) are increasingly being used to address chronic tendon degeneration and help patients regain function. For individuals struggling with ongoing tendon pain, a consultation with a regenerative medicine specialist can help determine whether these advanced therapies may be appropriate as part of a comprehensive treatment plan.

This field is for validation purposes and should be left unchanged.
Name